Fig. 1
From: Serum and exosome WNT5A levels as biomarkers in non-small cell lung cancer

Patient selection and clinical parameters. (A) Flow chart of patient selection in our prospective study; (B) Clinicopathologic parameters of NSCLC patients
From: Serum and exosome WNT5A levels as biomarkers in non-small cell lung cancer
Patient selection and clinical parameters. (A) Flow chart of patient selection in our prospective study; (B) Clinicopathologic parameters of NSCLC patients